Publication | Closed Access
Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/<i>lpr</i> mice
124
Citations
45
References
2005
Year
We prepared a novel potent Fkn antagonist and demonstrated its ability to delay the initiation and ameliorate the progression of lupus nephritis. This agent may therefore provide a new therapeutic approach to lupus nephritis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1